Structure of the Complement Factor 5a Receptor-Ligand Complex Studied by Disulfide Trapping and Molecular Modeling*

Complement factor 5a (C5a) is an anaphylatoxin that acts by binding to a G protein-coupled receptor, the C5aR. The relative orientation of this ligand-receptor pair is investigated here using the novel technique of disulfide trapping by random mutagenesis (DTRM) and molecular modeling. In the DTRM technique, an unpaired cysteine is introduced in the ligand, and a library of randomly mutagenized receptors is screened to identify mutants that introduce a cysteine at a position in the receptor that allows functional interactions with the ligand. By repeating this analysis at six positions of C5a, we identify six unique sets of intermolecular interactions for the C5a-C5aR complex, which are then compared with an independently developed computational three-dimensional model of the complex. This analysis reveals that the interface of the receptor N terminus with the cysteine-containing ligand molecules is selected from a variety of possible receptor conformations that exist in dynamic equilibrium. In contrast, DTRM identifies a single position in the second extracellular loop of the receptor that interacts specifically with a cysteine probe placed in the C-terminal tail of the C5a ligand.

[1]  J. Demartino,et al.  Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Gerard,et al.  The chemotactic receptor for human C5a anaphylatoxin , 1991, Nature.

[3]  J. Demartino,et al.  The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. , 1994, The Journal of biological chemistry.

[4]  H. Schiöth,et al.  The Repertoire of G-Protein–Coupled Receptors in Fully Sequenced Genomes , 2005, Molecular Pharmacology.

[5]  E. Zuiderweg,et al.  Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Underwood,et al.  Arginine 206 of the C5a Receptor Is Critical for Ligand Recognition and Receptor Activation by C-terminal Hexapeptide Analogs (*) , 1995, The Journal of Biological Chemistry.

[7]  F. Boulay,et al.  The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. , 1994, The Journal of biological chemistry.

[8]  J. Köhl,et al.  Site-Directed Mutagenesis of Conserved Charged Residues in the Helical Region of the Human C5a Receptor , 1996 .

[9]  M. Grossmann,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[10]  G. Nikiforovich,et al.  A Comprehensive Structure-Function Map of the Intracellular Surface of the Human C5a Receptor , 2007, Journal of Biological Chemistry.

[11]  G. Carter,et al.  Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a. , 1992, Journal of medicinal chemistry.

[12]  W. Boyar,et al.  Solution structure of a unique C5a semi‐synthetic antagonist: Implications in receptor binding , 1997, Protein science : a publication of the Protein Society.

[13]  E. Zuiderweg,et al.  Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. , 1989, Biochemistry.

[14]  P. Monk,et al.  The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity. , 1999, The journal of peptide research : official journal of the American Peptide Society.

[15]  F. Boulay,et al.  Evidence that the extracellular N‐terminal domain of C5aR contains amino‐acid residues crucial for C5a binding , 1993, European journal of haematology.

[16]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[17]  P. Monk,et al.  Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor. , 2001, Biochemistry.

[18]  A. Higginbottom,et al.  Comparative Agonist/Antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site* , 2005, Journal of Biological Chemistry.

[19]  Ian S Hagemann,et al.  Random Mutagenesis of the Complement Factor 5a (C5a) Receptor N Terminus Provides a Structural Constraint for C5a Docking* , 2006, Journal of Biological Chemistry.

[20]  Elaine C. Meng,et al.  An Activation Switch in the Ligand Binding Pocket of the C5a Receptor* , 2001, The Journal of Biological Chemistry.

[21]  J. Klco,et al.  Essential role for the second extracellular loop in C5a receptor activation , 2005, Nature Structural &Molecular Biology.

[22]  J. Klco,et al.  Genetic Analysis of the First and Third Extracellular Loops of the C5a Receptor Reveals an Essential WXFG Motif in the First Loop* , 2006, Journal of Biological Chemistry.

[23]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[24]  J. Thorner,et al.  Regulation of G protein-initiated signal transduction in yeast: paradigms and principles. , 2001, Annual review of biochemistry.

[25]  O. Lichtarge,et al.  C5a Receptor Activation , 1999, The Journal of Biological Chemistry.

[26]  F. Colotta,et al.  Targeting C5a: recent advances in drug discovery. , 2005, Current medicinal chemistry.

[27]  J. Köhl,et al.  Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor. , 1994, European journal of biochemistry.

[28]  A. Finch,et al.  Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity. , 1997, Journal of medicinal chemistry.

[29]  G. Marshall,et al.  Modeling flexible loops in the dark-adapted and activated states of rhodopsin, a prototypical G-protein-coupled receptor. , 2005, Biophysical journal.

[30]  Wayne A. Hendrickson,et al.  Structure of human follicle-stimulating hormone in complex with its receptor , 2005, Nature.

[31]  M. Marzioch,et al.  Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein α‐subunit chimeras , 2000, Yeast.

[32]  J. Drews Drug discovery: a historical perspective. , 2000, Science.

[33]  W. Boyar,et al.  Residues 21–30 within the Extracellular N-terminal Region of the C5a Receptor Represent a Binding Domain for the C5a Anaphylatoxin* , 1998, The Journal of Biological Chemistry.

[34]  O. Lichtarge,et al.  Genetic Mapping of the Human C5a Receptor , 2000, The Journal of Biological Chemistry.

[35]  Garland R Marshall,et al.  Three-dimensional model for meta-II rhodopsin, an activated G-protein-coupled receptor. , 2003, Biochemistry.

[36]  L. F. Kolakowski,et al.  Probing the Message:Address Sites for Chemoattractant Binding to the C5a Receptor , 1995, The Journal of Biological Chemistry.

[37]  W. Boyar,et al.  The pharmacophore of the human C5a anaphylatoxin , 1994, Protein science : a publication of the Protein Society.